Risk factors for totally implantable access ports-associated thrombosis in pediatric oncology patients

[1]  Max Andresen,et al.  Central catheter-associated deep vein thrombosis in cancer: clinical course, prophylaxis, treatment , 2021, BMJ Supportive & Palliative Care.

[2]  P. Demelo-Rodríguez,et al.  Inflammatory Biomarkers in the Short-Term Prognosis of Venous Thromboembolism: A Narrative Review , 2021, International journal of molecular sciences.

[3]  P. Moorehead,et al.  Incidence and risk factors of venous thrombotic events in pediatric patients with CNS tumors compared with non-CNS cancer: A population-based cohort study. , 2021, Thrombosis research.

[4]  S. Ahuja,et al.  Central venous catheter-related thrombosis in children and adults. , 2020, Thrombosis research.

[5]  R. Souza,et al.  Cancer-associated thrombosis: the when, how and why , 2019, European Respiratory Review.

[6]  J. Connors,et al.  Venous thromboembolism incidence in hematologic malignancies. , 2019, Blood reviews.

[7]  L. Jara-Palomares,et al.  D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis , 2018, British Journal of Cancer.

[8]  S. Laporte,et al.  Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP). , 2018, Blood.

[9]  T. Kent,et al.  Upper extremity deep venous thrombosis after port insertion: What are the risk factors? , 2017, Surgery.

[10]  Yan Jiang,et al.  Comparison of three types of central venous catheters in patients with malignant tumor receiving chemotherapy , 2017, Patient preference and adherence.

[11]  H. Abdel-Razeq,et al.  A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study , 2017, The oncologist.

[12]  J. Menéndez,et al.  Incidence and risk factors of superficial and deep vein thrombosis associated with peripherally inserted central catheters in children , 2016, Journal of thrombosis and haemostasis : JTH.

[13]  A. Agarwal,et al.  Risk factors for central venous catheter-related thrombosis in children: a retrospective analysis , 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[14]  K. Bailey,et al.  Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. , 2016, Thrombosis research.

[15]  G. Gensini,et al.  Incidence of ultrasound‐detected asymptomatic long‐term central vein catheter‐related thrombosis and fibrin sheath in cancer patients , 2015, European journal of haematology.

[16]  N. Rezaei,et al.  Inflammation in venous thromboembolism: Cause or consequence? , 2015, International immunopharmacology.

[17]  Cheng-Li Lin,et al.  A population-based cohort study. , 2015 .

[18]  M. Eyrich,et al.  Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience , 2014, BMC Hematology.

[19]  D. Hayoz,et al.  Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients , 2014, Journal of oncology.

[20]  C. Kellenberger,et al.  Port-a-cath-related thrombosis and postthrombotic syndrome in pediatric oncology patients. , 2013, The Journal of pediatrics.

[21]  M. Prins,et al.  International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer , 2013, Journal of thrombosis and haemostasis : JTH.

[22]  W. Ruf,et al.  Inflammation, obesity, and thrombosis. , 2012, Blood.

[23]  P. Marik,et al.  Narrative Review , 2012, Journal of intensive care medicine.

[24]  D. Bruusgaard.  [Cause of or consequence of?]. , 2011, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[25]  W. Scheithauer,et al.  Thrombosis risk and survival in cancer patients with elevated C‐reactive protein , 2011, Journal of thrombosis and haemostasis : JTH.

[26]  H. Tamary,et al.  Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer , 2010, Cancer.

[27]  S. Costa,et al.  An 11-year retrospective study of totally implanted central venous access ports: complications and patient satisfaction. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[28]  Gary H Lyman,et al.  Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.

[29]  W. Ageno,et al.  Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients , 2008, Internal and emergency medicine.

[30]  S Seeber,et al.  Risk factors for venous thromboembolic events in cancer patients. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  J. Williams,et al.  IN A POPULATION-BASED CASE-CONTROL STUDY , 2001 .

[32]  D. Marchant,et al.  Risk factors. , 1994, Obstetrics and gynecology clinics of North America.

[33]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .

[34]  Heisch Rb.  . . . and Why , 1963 .